Compliance Rate
Compliance Rate
40.0%
Compliant submissions
2
Incompliant submissions
3
Total trials
5
My Organizations' Clinical Trials
Showing 900 of 2418 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 09/20/23
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 01/23/25
End: 01/31/29
Due: 01/31/30
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 01/31/02
End: 01/31/18
Due: 01/31/19
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 03/17/20
End: 06/29/20
Due: 06/29/21
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 08/31/16
Due: 08/31/17
Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 06/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/29/20
End: 01/30/28
Due: 01/30/29
Phase: N/A
Priority: Normal
Start: 07/14/16
End: 01/12/21
Due: 01/12/22
Phase: N/A
Priority: Normal
Start: 07/31/13
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/25/17
End: 10/10/19
Due: 10/10/20
Phase: N/A
Priority: Normal
Start: 11/22/17
End: 08/19/19
Due: 08/19/20
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 02/01/20
Due: 02/01/21
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 10/09/19
End: 09/13/22
Due: 09/13/23
Phase: N/A
Priority: Normal
Start: 07/31/03
End: 11/30/07
Due: 11/30/08
Phase: N/A
Priority: Normal
Start: 10/17/17
End: 07/25/24
Due: 07/25/25
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 11/22/17
End: 09/20/19
Due: 09/20/20